You are about to action:

Object being modified by the action

Do you want to proceed?

Share Video Link

https://www.bitchute.com/video/zAkwE3pQYKGr/

Click to copy, then share by pasting into your messages, comments, social media posts and websites.

Embed Video HTML

Click to copy, then add into your webpages so users can view and engage with this video from your site.

Share to Social Media

Share to social media by clicking on the quick share links.

Report Content

Reason

Please select the most appropriate reason from the list provided.

Note: For a more detailed description of each reason, see our Community Guidelines.

Additional Comments

Please add any additonal comments that will help with the assessment of your request.

Note: Copyright claims must contain all the items specified within the Copyright Policy.

Email Submissions

We also accept reports via email. Please see the Guidelines Enforcement Process for instructions on how to make a request via email.

Thank you for submitting your report

We will investigate and take the appropriate action.

Add to Playlist

“SAFETY CONCERNS” HALT ANOTHER COVID DRUG TRIAL

Next video playing soon

Click to cancel

Autoplay has been paused

Click to watch next video

First published at 20:23 UTC on October 20th, 2020.

The Highwire with Del Bigtree

subscribers

Your platform for uncensored ideas. BitChute Premium.

BitChute Advertisement

“SAFETY CONCERNS” HALT ANOTHER COVID DRUG TRIAL

With media attention focused on the #COVID19 “vaccine unicorn”, several alternative therapeutics currently in trial are getting little attention. Monoclonal antibody cocktails,
touted by President Trump, claim to give Covid patients a boost of synthetic antibodies to help fight against the virus. Sounds great, but is there a catch? Eli Lilly has put their late-stage trial on hold due to a safety concern, leaving the public in the dark as to why.

#CovidTrials #Safety #EliLilly #OnHold #Health #Covid19 #TheHighWire

LESS